To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Dr. S. Vincent Rajkumar reviews his article appearing in the January 2020 issue of Mayo Clinic Proceedings which exposes the causes of and challenges for fixing the high cost of insulin in the United States.
The high price of pharmaceuticals and drugs is out of control. Sen. Sandy Pappas, Rep. Michael Nelson and Rep. Bob Vogel discuss ways to help.
In the last 5 years, cancer mortality has dropped 1.5 % equaling a financial reduction of approximately $750 Billion.
Debunking the myths supporting the current high costs associated with cancer treatment in the US.